SkinBioTherapeutics reports positive interim acne study findings
27th Feb 2024 15:44
(Sharecast News) - Life science company SkinBioTherapeutics reported encouraging interim findings from its ongoing AxisBiotix acne food supplement study featuring its lead formulation on Tuesday.
Read moreSkinBioTherapeutics finalises acquisition of Dermatronics
26th Jan 2024 16:04
(Sharecast News) - SkinBioTherapeutics announced on Friday that it has finalised the acquisition of Dermatonics, known for its topical and dermatological products within the skincare and wound care sector.
Read moreSkinBioTherapeutics launches new consumer study into acne
25th Oct 2023 09:08
(Sharecast News) - Life sciences company SkinBioTherapeutics said on Wednesday that it had begun a new consumer study into acne, with two new formulas set to be trialled in order to compare efficacy against "the most common skin condition".
Read moreSkinBioTherapeutics gets France approval for psoriasis supplement
15th Sep 2023 10:11
(Sharecast News) - SkinBioTherapeutics has been given the green light by French regulators to introduce its food supplement, AxisBiotix-Ps, into the French market, it announced on Friday.
Read moreSkinBioTherapeutics selects probiotic blends for acne study
5th Sep 2023 12:44
(Sharecast News) - Skin health specialist SkinBioTherapeutics updated the market on its decision on the probiotic blends to be used in a consumer volunteer study aimed at acne treatment on Tuesday.
Read moreSkinBioTherapeutics launching psoriasis supplement in Italy
21st Jun 2023 17:00
(Sharecast News) - Skin health specialist SkinBioTherapeutics has received regulatory approval to introduce 'AxisBiotix-Ps' - a food supplement designed to alleviate the symptoms associated with psoriasis - into the Italian market, it announced on Wednesday.
Read moreSkinBioTherapeutics pleased with progress on two fronts
10th May 2023 13:05
(Sharecast News) - Skin health-focussed life science company SkinBioTherapeutics said in an update on Wednesday that its partner Sederma, a division of Croda International, was planning to undertake additional studies on SkinBiotix.
Read moreSkinBioTherapeutics reports progress with psoriasis supplement roll-out
17th Feb 2022 15:34
(Sharecast News) - SkinBioTherapeutics updated the market on Thursday on the commercialisation of its food supplement product 'AxisBiotix-Ps', designed for the symptoms of psoriasis.
Read moreSkinBioTherapeutics commercially launches psoriasis supplement
29th Oct 2021 12:48
(Sharecast News) - Skin health-focussed life sciences company SkinBioTherapeutics announced the commercial launch of 'AxisBiotix-Ps' on Friday, which it described as a probiotic food supplement to help alleviate the symptoms of psoriasis.
Read moreSkinBioTherapeutics confirms launch plans for psoriasis supplement
30th Sep 2021 15:38
(Sharecast News) - Skin health-focussed life science company SkinBioTherapeutics updated the market on its commercialisation plans for 'AxisBiotix-Ps' on Thursday, which it described as its probiotic food supplement to help alleviate the symptoms associated with psoriasis.
Read moreSkinBioTherapeutics launches research programme with Manchester University
8th Apr 2021 13:01
(Sharecast News) - Skin health science company SkinBioTherapeutics has initiated a research programme with the University of Manchester, it announced on Thursday, to investigate and develop microbiome formulations that support natural anti-inflammatory response to a range of environmental challenges.
Read moreSkinBioTherapeutics confident in timelines amid Covid crisis
7th Jul 2020 13:42
(Sharecast News) - SkinBioTherapeutics updated the market on its operations on Tuesday, reporting that it ended the 12 months to 30 June with a "solid" cash balance of £2.1m, down from £2.5m at the end of December.
Read moreSkinBioTherapeutics to develop psoriasis supplement with Winclove
19th Feb 2020 14:48
(Sharecast News) - Skin health-focussed life science company SkinBioTherapeutics announced on Wednesday that its wholly-owned subsidiary, AxisBiotix, has signed a development agreement with Winclove Probiotics, to help manage the symptoms associated with the skin condition, psoriasis.
Read moreSkinBioTherapeutics strikes deal with chemicals giant Croda
20th Nov 2019 11:15
(Sharecast News) - Skin health-focussed life sciences company SkinBioTherapeutics has signed a commercial agreement with speciality chemicals giant Croda International, it announced on Wednesday.
Read moreSkinBioTherapeutics pleased with first human study results
8th Apr 2019 09:08
(Sharecast News) - Skin health-focussed life sciences company SkinBioTherapeutics released the results of its first human study on Monday, which was primarily undertaken to show the effects of its 'SkinBiotix' product on the barrier of healthy skin.
Read more